Herd Immunity: A Major Advantage or A Major Challenge to Achieve for the COVID-19 Pandemic
DOI:
https://doi.org/10.37506/ijfmt.v15i1.13444Keywords:
COVID-19, SARS-COV2, herd immunity, vaccination, pandemicAbstract
COVID-19 caused by the novel SARS-COV2 has been causing worldwide panic in recent times. Global
epidemiological findings have shown numerous new cases being reported daily as well as drastic mortality
rates. It is the need of the hour to plan out strategies to cope with this ongoing pandemic. Herd immunity
has been used as an effective approach for years during epidemics and can prove to be a major advantage in
controlling the spread of the disease. Various models have been studied using mathematical estimates to find
out how herd immunity can be achieved as well as to predict risks involved in doing so. The current scenario
where there are no efficient vaccines available has also been taken into consideration. It is important to take
all these facts into consideration to come to a valid conclusion of whether achieving herd immunity can be
beneficial or impractical.
Published
How to Cite
Issue
Section
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Re use and mixing of content policy- We follow Creative Commons Licence Policy. We follow CC BY. Please refer below for all details
https://creativecommons.org/licenses/
CC BY
This license lets others distribute, remix, adapt, and build upon our work, even commercially, as long as they credit us for the original creation.
- The journal allows readers to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose.
- The journal allows the author(s) to hold the copyright without restrictions.
- The journal allows the author(s) to retain publishing rights without restrictions
